Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;39(3):295-305.
doi: 10.1007/s00281-016-0597-6. Epub 2016 Oct 27.

Myeloid-derived suppressor cells and tumor escape from immune surveillance

Affiliations
Review

Myeloid-derived suppressor cells and tumor escape from immune surveillance

Viktor Umansky et al. Semin Immunopathol. 2017 Apr.

Abstract

Tumor progression is known to be supported by chronic inflammatory conditions developed in the tumor microenvironment. It is characterized by the long-term secretion of various inflammatory soluble factors (including cytokines, chemokines, growth factors, reactive oxygen and nitrogen species, prostaglandins, etc.) and strong leukocyte infiltration. Among leukocytes infiltrating tumors, myeloid-derived suppressor cells (MDSCs) represent one of the most important players mediating immunosuppression and supporting tumor escape. These cells can strongly inhibit antitumor immune reactions mediated by T cells and NK cells. Moreover, MDSCs are generated, recruited to the tumor site, and activated not only under the influence of soluble inflammatory mediators but also due to extracellular vesicles (EVs) secreted by tumor cells. EVs play a key role in the formation of MDSCs via the conversion of normal myeloid cells and altering the normal myelopoiesis. In addition, EVs help create a suitable microenvironment for the metastatic process.

Keywords: Cancer; Chronic inflammatory factors; Extracellular microvesicles; Immunosuppression; Myeloid-derived suppressor cells; Tumor microenvironment.

PubMed Disclaimer

References

    1. Anticancer Res. 1998 Sep-Oct;18(5A):3433-7 - PubMed
    1. Semin Cancer Biol. 2012 Aug;22(4):307-18 - PubMed
    1. Nat Cell Biol. 2016 Sep;18(9):1006-17 - PubMed
    1. Cancer Res. 2010 Jan 1;70(1):99-108 - PubMed
    1. Adv Med Sci. 2015 Mar;60(1):83-8 - PubMed

MeSH terms

LinkOut - more resources